Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Lawrence

Showing results (41-50 of 299) with videos related to

Pageof 30
Sort By:
Journal of Chemical Neuroanatomy|April 6, 2015
Distribution of the orexin-1 receptor (OX1R) in the mouse forebrain and rostral brainstem: A characterisation of OX1R-eGFP miceSarah Sulaiman Ch'ng, Andrew J Lawrence
Journal of Neurochemistry|March 7, 2023
Journal of Neurochemistry embraces Transparent Peer ReviewAndrew J Lawrence, Marco A M Prado
Journal of Neurochemistry|April 2, 2004
Neuropeptides: implications for alcoholismMichael S Cowen, Feng Chen, Andrew J Lawrence
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2003
Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St John's wort treatmentFeng Chen, Amir H Rezvani, Andrew J Lawrence
Physiology & Behavior|August 6, 2019
Environmental enrichment reduces the propensity to relapse following punishment-imposed abstinence of alcohol seekingErin J Campbell, Shubo Jin, Andrew J Lawrence
The American Journal of Chinese Medicine|January 8, 2011
Traditional Chinese medicine for treatment of alcoholism: from ancient to modernQing Liu, Andrew J Lawrence, Jian-Hui Liang
Neuroscience and Biobehavioral Reviews|February 26, 2008
Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studiesAntonio Verdejo-García, Andrew J Lawrence, Luke Clark
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2005
The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systemsMichael S Cowen, Elvan Djouma, Andrew J Lawrence
Psychopharmacology|November 11, 2006
Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonismMichael S Cowen, Elena Krstew, Andrew J Lawrence
Psychopharmacology|March 26, 2018
New steps for treating alcohol use disorderErin J Campbell, Andrew J Lawrence, Christina J Perry
Pageof 30

Showing results (41-50 of 299) with videos related to

Sort By:
Pageof 30
Journal of Chemical Neuroanatomy|April 6, 2015
Distribution of the orexin-1 receptor (OX1R) in the mouse forebrain and rostral brainstem: A characterisation of OX1R-eGFP miceSarah Sulaiman Ch'ng, Andrew J Lawrence
Journal of Neurochemistry|March 7, 2023
Journal of Neurochemistry embraces Transparent Peer ReviewAndrew J Lawrence, Marco A M Prado
Journal of Neurochemistry|April 2, 2004
Neuropeptides: implications for alcoholismMichael S Cowen, Feng Chen, Andrew J Lawrence
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2003
Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St John's wort treatmentFeng Chen, Amir H Rezvani, Andrew J Lawrence
Physiology & Behavior|August 6, 2019
Environmental enrichment reduces the propensity to relapse following punishment-imposed abstinence of alcohol seekingErin J Campbell, Shubo Jin, Andrew J Lawrence
The American Journal of Chinese Medicine|January 8, 2011
Traditional Chinese medicine for treatment of alcoholism: from ancient to modernQing Liu, Andrew J Lawrence, Jian-Hui Liang
Neuroscience and Biobehavioral Reviews|February 26, 2008
Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studiesAntonio Verdejo-García, Andrew J Lawrence, Luke Clark
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2005
The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systemsMichael S Cowen, Elvan Djouma, Andrew J Lawrence
Psychopharmacology|November 11, 2006
Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonismMichael S Cowen, Elena Krstew, Andrew J Lawrence
Psychopharmacology|March 26, 2018
New steps for treating alcohol use disorderErin J Campbell, Andrew J Lawrence, Christina J Perry
Pageof 30